Aurinia: Q1 Earnings Snapshot

May 10, 2022 GMT

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $37.6 million in its first quarter.

On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 27 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.

The biotechnology company posted revenue of $21.6 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $19.7 million.

Aurinia expects full-year revenue in the range of $115 million to $135 million.

Aurinia shares have fallen 61% since the beginning of the year. The stock has declined 12% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AUPH at